Hodgkin Disease Pediatric

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-05
Clinical Trial Update: Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) [Phase 2]
Phase 2 trial update for autologous CD30.CAR-T cells in relapsed/refractory Hodgkin lymphoma (CHARIOT) is ongoing (Phase 2, active not recru…